Treatment of hepatitis C virus infection in the future

Two direct-acting antivirals (DAAs) against hepatitis C virus (HCV): telaprevir and boceprevir, are now available in combination with peginterferon plus ribavirin for the treatment of chronic hepatitis C infection. Although these drugs are potent inhibitors of HCV replication, they occasionally resu...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanda, Tatsuo, Yokosuka, Osamu, Omata, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637513/
https://www.ncbi.nlm.nih.gov/pubmed/23577631
http://dx.doi.org/10.1186/2001-1326-2-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3637513/
https://www.ncbi.nlm.nih.gov/pubmed/23577631
http://dx.doi.org/10.1186/2001-1326-2-9

Ejemplares similares